-
Nov 27, 13 Drug News
The FDA has loosened restrictions on the diabetes drug rosiglitazone (Avandia) - under fire since 2007 because of potential cardiovascular… »
Nov 27, 13 FDA ApprovalsA third agent that acts directly against hepatitis C (HCV) has been approved, according to the company that makes the… »
Nov 26, 13 Clinical UpdatesHealth regulators said on Monday they would lift restrictions on the use of GlaxoSmithKline Plc’s once widely prescribed diabetes drug… »
Nov 23, 13 Clinical UpdatesWomen using a popular acne drug that causes birth defects need better information about how to keep from getting pregnant,… »
Nov 23, 13 FDA ApprovalsThe U.S. Food and Drug Administration said on Friday it has expanded the approved use of the cancer drug… »
Nov 22, 13 Clinical UpdatesDrugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other… »
Nov 21, 13 Drug NewsIn the field of drug design, the protein K-Ras is legendary. It’s been on everyone’s “target” list for more than… »
Nov 20, 13 Clinical UpdatesAmgen Inc’s experimental heart medicine from a closely watched new class of drugs called PCSK9 inhibitors lowered “bad” LDL cholesterol… »
Nov 19, 13 FDA ApprovalsGlaxoSmithKline and Theravance’s new inhaled lung drug Relvar has been approved in Europe to treat both asthma and chronic obstructive… »
Nov 19, 13 Drug NewsHorizon Pharma Inc said it would buy the right to market AstraZeneca Plc’s arthritis drug Vimovo in the United… »
Subscribe to the "News" RSS Feed
TOP ۞